$GWH
ESS Tech, Inc.

2023 Q3 Form 10-Q Financial Statement

#000162828023028300 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $1.545M $2.827M
YoY Change 704.69% 312.1%
Cost Of Revenue $10.18M $0.00
YoY Change
Gross Profit -$8.638M $2.827M
YoY Change -4598.96%
Gross Profit Margin -559.09% 100.0%
Selling, General & Admin $7.887M $7.584M
YoY Change 1.17% -12.8%
% of Gross Profit 268.27%
Research & Development $1.609M $19.45M
YoY Change -92.01% 20.32%
% of Gross Profit 688.01%
Depreciation & Amortization $1.100M $1.000M
YoY Change 207.26% 283.14%
% of Gross Profit 35.37%
Operating Expenses $9.496M $27.03M
YoY Change -65.99% 8.74%
Operating Profit -$18.13M -$24.21M
YoY Change -34.61% 0.13%
Interest Expense $1.500M $1.220M
YoY Change 92.06% 78.1%
% of Operating Profit
Other Income/Expense, Net $1.516M $1.278M
YoY Change -139.21% -85.12%
Pretax Income -$16.62M -$22.93M
YoY Change -47.4% 47.1%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$16.62M -$22.93M
YoY Change -47.41% 47.09%
Net Earnings / Revenue -1075.6% -811.07%
Basic Earnings Per Share -$0.11 -$0.15
Diluted Earnings Per Share -$0.11 -$0.15
COMMON SHARES
Basic Shares Outstanding 155.6M shares 154.4M shares
Diluted Shares Outstanding 157.1M shares 154.9M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $124.5M $99.50M
YoY Change -25.33% -48.22%
Cash & Equivalents $37.17M $30.29M
Short-Term Investments $87.30M $69.20M
Other Short-Term Assets $3.100M $4.400M
YoY Change -29.94% -5.64%
Inventory $2.256M
Prepaid Expenses
Receivables $1.265M $1.393M
Other Receivables $0.00 $0.00
Total Short-Term Assets $131.4M $105.4M
YoY Change -23.25% -47.13%
LONG-TERM ASSETS
Property, Plant & Equipment $17.99M $18.48M
YoY Change 12.78% 48.33%
Goodwill
YoY Change
Intangibles $4.990M
YoY Change
Long-Term Investments
YoY Change
Other Assets $824.0K $115.0K
YoY Change 170.16% -50.85%
Total Long-Term Assets $27.23M $22.34M
YoY Change 32.05% 33.37%
TOTAL ASSETS
Total Short-Term Assets $131.4M $105.4M
Total Long-Term Assets $27.23M $22.34M
Total Assets $158.7M $127.8M
YoY Change -17.31% -40.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.192M $2.838M
YoY Change 192.58% 97.77%
Accrued Expenses $13.40M $15.00M
YoY Change -6.3% 50.62%
Deferred Revenue $1.400M $3.200M
YoY Change -60.52% -52.96%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.127M
YoY Change -100.0% -60.15%
Total Short-Term Liabilities $18.64M $22.71M
YoY Change -15.76% 3.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.64M $22.71M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $42.20M $30.46M
YoY Change 25.59% 4.05%
SHAREHOLDERS EQUITY
Retained Earnings -$680.0M -$663.4M
YoY Change 14.58% 18.06%
Common Stock $18.00K $16.00K
YoY Change 12.5% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $116.5M $97.30M
YoY Change
Total Liabilities & Shareholders Equity $158.7M $127.8M
YoY Change -17.31% -40.89%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$16.62M -$22.93M
YoY Change -47.41% 47.09%
Depreciation, Depletion And Amortization $1.100M $1.000M
YoY Change 207.26% 283.14%
Cash From Operating Activities -$1.220M -$19.02M
YoY Change -94.48% 25.47%
INVESTING ACTIVITIES
Capital Expenditures $770.0K $830.0K
YoY Change -128.28% -118.77%
Acquisitions
YoY Change
Other Investing Activities -$17.15M -$37.31M
YoY Change -60.91% -53.13%
Cash From Investing Activities -$17.92M -$38.14M
YoY Change -61.54% -54.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 26.03M -140.0K
YoY Change -4974.53% -68.4%
NET CHANGE
Cash From Operating Activities -1.220M -19.02M
Cash From Investing Activities -17.92M -38.14M
Cash From Financing Activities 26.03M -140.0K
Net Change In Cash 6.890M -57.30M
YoY Change -109.95% -42.48%
FREE CASH FLOW
Cash From Operating Activities -$1.220M -$19.02M
Capital Expenditures $770.0K $830.0K
Free Cash Flow -$1.990M -$19.85M
YoY Change -89.72% 84.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3148000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5657000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
105417000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
151636000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18483000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17570000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2797000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3401000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
944000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
675000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
115000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
271000 usd
CY2023Q2 us-gaap Assets
Assets
127756000 usd
CY2022Q4 us-gaap Assets
Assets
173553000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2838000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3036000 usd
CY2023Q2 ghw Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
8970000 usd
CY2022Q4 ghw Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
14125000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
5103000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1643000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1500000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1421000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3167000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6168000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1127000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1600000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
22705000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27993000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
315000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3348000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2442000 usd
CY2023Q2 ghw Common Stock Warrant Liabilities
CommonStockWarrantLiabilities
2636000 usd
CY2022Q4 ghw Common Stock Warrant Liabilities
CommonStockWarrantLiabilities
3209000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
85000 usd
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154900330 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154900330 shares
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19450000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16165000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37181000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29063000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1739000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1900000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3592000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3402000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5845000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6797000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11132000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14586000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
27034000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
24862000 usd
us-gaap Operating Expenses
OperatingExpenses
51905000 usd
us-gaap Operating Expenses
OperatingExpenses
47051000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-24207000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-24176000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-48706000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-46365000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1330000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
247000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2582000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
115000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-25101000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-255000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
721000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-251000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1278000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8588000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3876000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25068000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22929000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-22929000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-15588000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15588000 usd
us-gaap Net Income Loss
NetIncomeLoss
-44830000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44830000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21297000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21297000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152723980 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152723980 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154514265 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154514265 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152206773 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152206773 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
205159000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
47000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2808000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2760000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5709000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
199449000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
48000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2945000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-15588000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
186854000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
136974000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
104000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2059000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21901000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
117236000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
268000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2725000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-22929000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
97300000 usd
us-gaap Net Income Loss
NetIncomeLoss
-44830000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21297000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2105000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
463000 usd
ghw Non Cash Interest Income Expense
NonCashInterestIncomeExpense
-1487000 usd
ghw Non Cash Interest Income Expense
NonCashInterestIncomeExpense
7000 usd
ghw Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
604000 usd
ghw Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
555000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4784000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5705000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-25101000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
33000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-238000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4653000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1841000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2561000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1336000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-664000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-786000 usd
ghw Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-4234000 usd
ghw Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
1961000 usd
ghw Increase Decrease In Product Warranty Accrual
IncreaseDecreaseInProductWarrantyAccrual
3460000 usd
ghw Increase Decrease In Product Warranty Accrual
IncreaseDecreaseInProductWarrantyAccrual
1158000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3189000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-687000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-689000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
74000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37532000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34533000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3440000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8463000 usd
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-37363000 usd
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
79599000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
33923000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88062000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
800000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
967000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
122000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
95000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
332000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
82000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2808000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-14000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-442000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3687000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4051000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-126282000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36655000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240232000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32604000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113950000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
827000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
806000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
931000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
556000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4534000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
123000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30287000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112708000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1373000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1167000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
944000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
75000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32604000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113950000 usd
ghw Battery Flexible Energy Capacity Minimum
BatteryFlexibleEnergyCapacityMinimum
4 h
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Certain immaterial prior year amounts have been reclassified to conform with current year presentation. These reclassifications had no effect on the reported results of operations.</span>
CY2023Q2 us-gaap Depreciation
Depreciation
1000000.0 usd
CY2022Q2 us-gaap Depreciation
Depreciation
261000 usd
us-gaap Depreciation
Depreciation
2100000 usd
us-gaap Depreciation
Depreciation
457000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23423000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20411000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4940000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2841000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18483000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17570000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3220000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2948000 usd
CY2023Q2 ghw Materials And Related Purchases Current
MaterialsAndRelatedPurchasesCurrent
3147000 usd
CY2022Q4 ghw Materials And Related Purchases Current
MaterialsAndRelatedPurchasesCurrent
6892000 usd
CY2023Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
1014000 usd
CY2022Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
770000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
755000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1011000 usd
CY2023Q2 ghw Accrued Capital Expenditures
AccruedCapitalExpenditures
224000 usd
CY2022Q4 ghw Accrued Capital Expenditures
AccruedCapitalExpenditures
1093000 usd
CY2023Q2 ghw Other Accrued Liability And Other Liabilities Current
OtherAccruedLiabilityAndOtherLiabilitiesCurrent
610000 usd
CY2022Q4 ghw Other Accrued Liability And Other Liabilities Current
OtherAccruedLiabilityAndOtherLiabilitiesCurrent
1411000 usd
CY2023Q2 ghw Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
8970000 usd
CY2022Q4 ghw Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
14125000 usd
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2874000 usd
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1643000 usd
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3674000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1805000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5178000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1805000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
789000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
647000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1062000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
647000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-656000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
0 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-656000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
0 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
5103000 usd
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1158000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
5103000 usd
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1158000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1127000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1915000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1127000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1600000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
315000 usd
CY2023Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
75000 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11461227 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11461227 shares
ghw Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0 shares
ghw Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
0 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11461227 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11461247 shares
ghw Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0 shares
ghw Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
20 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
12500 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
12500 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2725000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2945000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4784000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5705000 usd
CY2023Q2 ghw Share Based Compensation Arrangement By Share Based Payment Awards Potential Increase In Shares Authorized Percentage Of Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardsPotentialIncreaseInSharesAuthorizedPercentageOfSharesOutstanding
0.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3223109 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.01
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4583000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
349545 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.35
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
298358 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.46
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2575206 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.16
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2437000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1947123 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.76
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y21D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
3244000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1902554 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.91
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y5M23D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1915000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
28600000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y11M12D
us-gaap Debt Securities Trading Gain Loss
DebtSecuritiesTradingGainLoss
-11000 usd
CY2023Q2 us-gaap Debt Securities Trading Gain Loss
DebtSecuritiesTradingGainLoss
-11000 usd
us-gaap Debt Securities Trading Gain Loss
DebtSecuritiesTradingGainLoss
-185000 usd
CY2022Q2 us-gaap Debt Securities Trading Gain Loss
DebtSecuritiesTradingGainLoss
-185000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2827000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
686000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3199000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
686000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
119000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
11000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6515000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8610000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
108000 usd
ghw Contract With Customer Liability Period Increase Decrease
ContractWithCustomerLiabilityPeriodIncreaseDecrease
-2100000 usd
ghw Contract With Customer Liability Advance Payment
ContractWithCustomerLiabilityAdvancePayment
1500000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3200000 usd
ghw Contract With Customer Liability Deposits Returned To Customers
ContractWithCustomerLiabilityDepositsReturnedToCustomers
108000 usd
ghw Contract With Customer Liability Change In Estimate Of Variable Consideration
ContractWithCustomerLiabilityChangeInEstimateOfVariableConsideration
244000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3200000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3300000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-22929000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22929000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-15588000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15588000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-44830000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44830000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21297000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21297000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154900330 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154900330 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152723980 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152723980 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154514265 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154514265 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152206773 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152206773 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26662110 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26662110 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20617562 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20617562 shares
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-23-028300-index-headers.html Edgar Link pending
0001628280-23-028300-index.html Edgar Link pending
0001628280-23-028300.txt Edgar Link pending
0001628280-23-028300-xbrl.zip Edgar Link pending
exhibit311-ceocertq22023.htm Edgar Link pending
exhibit312-cfocertq22023.htm Edgar Link pending
exhibit321-ceocertq22023.htm Edgar Link pending
exhibit322-cfocertq22023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ghw-20230630.htm Edgar Link pending
ghw-20230630.xsd Edgar Link pending
ghw-20230630_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ghw-20230630_lab.xml Edgar Link unprocessable
ghw-20230630_pre.xml Edgar Link unprocessable
ghw-20230630_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ghw-20230630_def.xml Edgar Link unprocessable
ghw-20230630_cal.xml Edgar Link unprocessable